Our findings not only suppose that CLIC2 is a modifier for DCM, and it also highlights the genomic diversity in important ion channels that are intentionally or as side effects targeted by anti‐arrhythmic drugs. This evidence concerns the gene CLIC2 and familial dilated cardiomyopathy.